Expression of complement components differs between kidney allografts from living and deceased donors

Area of Science:

• Nephrology
• Transplantation Immunology
• Genomics

Background:

• Renal allograft survival differs significantly between living and deceased donors.
• Understanding molecular disparities can lead to targeted therapies for enhanced graft survival.
• The complement system's role in renal allograft outcomes requires further investigation.

Purpose of the Study:

• To examine whole genome expression profiles in human renal allografts to identify molecular mechanisms underlying donor source disparities.
• To investigate the association between gene expression, particularly complement pathway genes, and renal allograft function.
• To explore the impact of peritransplantation factors on gene expression and graft outcomes.

Main Methods:

• Microarray analysis of whole genome expression profiles from 53 human renal allograft protocol biopsies.
• Comparison of gene expression between living-donor and deceased-donor kidneys at implantation and post-transplantation.
• Correlation of complement gene expression with donor characteristics, peritransplantation phenomena, and graft function.

Main Results:

• Significant differences in gene expression profiles were observed between living-donor and deceased-donor kidneys pre-reperfusion.
• Deceased-donor kidneys showed increased renal expression of complement genes.
• Increased complement gene expression post-transplantation was noted in well-functioning, non-rejecting kidneys, irrespective of donor source.
• Peritransplantation factors like donor death and cold ischemia time influenced complement pathway gene expression.
• Implantation-time complement gene expression correlated with both early and late graft function.

Conclusions:

• Complement pathway activation is implicated in renal allograft outcomes.
• Peritransplantation factors significantly influence complement gene expression.
• Complement gene expression at implantation serves as a predictive marker for graft function.
• Targeting the complement system may represent a promising therapeutic strategy to improve renal allograft survival.